Repository logo
 

The MesoVATS trial: is there a future for video-assisted thoracoscopic surgery partial pleurectomy?

Accepted version
Peer-reviewed

No Thumbnail Available

Type

Article

Change log

Authors

Rintoul, Robert C 

Abstract

Malignant pleural mesothelioma, a uniformly fatal cancer caused by prior asbestos exposure, places a major burden on society. The MesoVATS trial was a multicenter randomized controlled trial that examined the role of video-assisted thoracoscopic partial pleurectomy (VAT-PP) versus talc pleurodesis in patients with malignant pleural mesothelioma. Overall there was no difference in survival between VAT-PP and talc pleurodesis. VAT-PP resulted in more complications, longer hospital stay and was more expensive. However, there was some evidence that VAT-PP improved EQ5D measured quality of life after 6 months particularly in the European Organisation for Research and Treatment of Cancer low-risk subgroup. At present the future role of VAT-PP is uncertain and may merit further investigation but this should be within the context of clinical trials. VAT-PP may also have a role to play in the specific situation of trapped lung.

Description

Keywords

mesothelioma, partial pleurectomy, video-assisted thoracoscopic surgery, Aged, Clinical Trials as Topic, Female, Humans, Lung Neoplasms, Male, Mesothelioma, Mesothelioma, Malignant, Multicenter Studies as Topic, Pleural Neoplasms, Quality of Life, Randomized Controlled Trials as Topic, Thoracic Surgery, Video-Assisted

Journal Title

Future Oncol

Conference Name

Journal ISSN

1479-6694
1744-8301

Volume Title

11

Publisher

Informa UK Limited